Get the Daily Brief
Latest Biotech News
Artificial Intelligence Enhances Drug Response Prediction via Single-Cell Resolution
Researchers have developed CRISP, a novel transfer learning framework that predicts drug perturbation responses in previously untested cell types at single-cell resolution. This approach addresses...
FDA Approves Jazz-Roche Combo for First-Line Lung Cancer Maintenance
The U.S. Food and Drug Administration approved a priority supplemental New Drug Application (sNDA) for the combination of Jazz Pharmaceuticals' Zepzelca (lurbinectedin) with Roche's Tecentriq...
AI-Driven Discovery of New Antimicrobials and Protein Design Risks
Researchers employed generative artificial intelligence to identify novel antimicrobial peptides effective against multidrug-resistant bacteria strains, representing a promising step in combating...
Breakthroughs in Organ Transplantation Using Enzyme Technology
Scientists at the University of British Columbia achieved the first human transplant of a kidney converted from blood type A to the universal type O using specialized enzymes. This...
Novel Psilocybin Effects on Chronic Pain and Depression in Mice
University of Pennsylvania researchers discovered that a single dose of psilocybin rapidly and sustainably alleviates both chronic pain and associated depressive-like behaviors in mouse models....
Advances in AI-Enabled Drug Discovery Collaborations
Pharma giants Bristol Myers Squibb, Takeda, and Astex Pharmaceuticals have jointly contributed proprietary structural biology data to train OpenFold3, an AI model aimed at accelerating drug...
Largest Genetic Map of Human Metabolism Unveiled
A study using data from approximately 450,000 UK Biobank participants constructed the most extensive genetic map linking human genetics to metabolic traits. The research identified nearly 30,000...
Cartography Biosciences Raises $67 Million to Advance Colorectal Cancer Drug
Cartography Biosciences secured $67 million in a Series B financing round led by Pfizer Ventures to advance its lead T-cell engaging bispecific antibody program targeting colorectal cancer. The...
Sport and Mental Health Link: Parkrun Study Shows Improved Life Satisfaction
A novel longitudinal study analyzed participants of weekly 5-kilometer Parkrun events, revealing that mental health improvements are the strongest predictors of increased life satisfaction. The...
Open Access RNA-Protein Interaction Mapping for Disease Insights
Bioengineers at the University of California San Diego developed a new technology capable of mapping comprehensive RNA-protein interaction networks inside human cells. This powerful tool...
European Consolidation: Asabys Partners Merges Aliath Bioventures in €468M Deal
The European life sciences investment landscape sees significant consolidation as Asabys Partners integrates Aliath Bioventures, creating a combined firm with over €468 million assets under...
Jazz and Roche Win FDA Nod for Lung Cancer Maintenance Combo
The U.S. FDA approved Jazz Pharmaceuticals and Roche's combination therapy for extensive-stage small-cell lung cancer (SCLC) as first-line maintenance treatment. The approval, based on the phase...
UBC's Enzyme Technology Enables Universal Donor Kidney Transplant
Researchers at the University of British Columbia achieved a first-in-human transplant of a kidney enzymatically converted from type A to universal type O blood group. This enzymatic treatment...
Microsoft Demonstrates AI-Designed Toxins Bypassing Biosecurity Screening
Microsoft researchers showcased the potential for generative AI to design protein toxins that evade current DNA synthesis screening software. By redesigning known toxins while preserving their...
Breakthroughs in Pediatric Brain Cancer Prognosis via MRI Radiomics
A novel MRI radiomics technique has been developed to predict survival outcomes in isocitrate dehydrogenase wild type glioblastoma (IDH-wt GBM), a highly aggressive brain tumor. Published in BMC...
AI and Machine Learning Propel Drug Discovery and Metabolic Research
Artificial intelligence is increasingly integral to drug discovery, as exemplified by the OpenFold3 project where pharma giants Bristol Myers Squibb, Takeda, and Astex pool data to accelerate AI...
Gene Editing Advances: Synthetic Proteins and DNA Repair Catalog Unveiled
Cutting-edge research introduced synthetic proteins designed via generative AI that outperform natural genome-editing proteins, enhancing precision and efficiency in gene editing. Complementing...
Psilocybin Shows Promise for Treating Chronic Pain and Depression in Mice
Researchers at the University of Pennsylvania demonstrated that a single dose of psilocybin effectively reduces hypersensitivity and anxiety-depressive behaviors in mouse models of chronic pain....
Takeda Exits Cell Therapy, Refocuses Pipeline on Small Molecules and ADCs
Takeda Pharmaceutical Co. Ltd. announced its strategic exit from cell therapy research and development, seeking external partners to advance existing programs. The company is not currently running...
Significant Uptick in Biopharma Financing Amid Market Challenges
Biopharma financing showed a 54% rise in September 2025, reaching $7.12 billion, contributing to a $47.1 billion total for the first nine months of the year. Despite being markedly lower than...